Article

Software, hardware upgrades make phaco unit safer

San Francisco-The new software and hardware upgrades to the Sovereign phacoemulsification system (Advanced Medical Optics [AMO]) make cataract surgery safer and more efficient, based on the results of three studies of the WhiteStar ICE (Increased Control and Efficiency) technology (AMO) reported at the annual meeting of the American Society of Cataract and Refractive Surgery.

What is especially noteworthy from the studies is the increased stability of the anterior chamber that is provided by the CASE (chamber stabilization environment) component of the system.

Software, hardware upgrades

"A few years ago, cool phaco was the subject of interest and WhiteStar . . . moved the technology forward to minimize the application of ultrasound energy during cataract surgery," Dr. Auffarth explained. "Now the manufacturer has moved on to the 'ICE age,' which is concerned not with cool phaco but with increased control and efficiency of phaco."

"These new features provide more stability, more safety, and more freedom when using higher settings, especially for flow rate and vacuum," Dr. Auffarth said. "The surgeon can even manipulate the shape of the microburst during surgery. These changes represent fine-tunings of the system that the surgeon does not feel during surgery."

Dr. Auffarth and colleagues conducted a pre-market-release study of the WhiteStar ICE System with the approval of the ethics committee of their institution. Initially, they were limited to including 32 consecutive patients (mean age, 71.3 ± 5.4 years) undergoing cataract surgery. First, the investigators used the Pentacam Scheimpflug camera to measure the cataract densities, flaremeter, and the anterior chamber depth volume.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.